FELMETATUG VEDOTIN
UNII VG5Y3A9DFS

Substance Identification & Data

This profile provides standardized clinical and technical data for Felmetatug Vedotin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) VG5Y3A9DFS.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2924808-30-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
VG5Y3A9DFS
CAS Registry Number
2924808-30-8
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
FELMETATUG VEDOTIN
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C186669
National Cancer Institute reference terminology for clinical and research data.
INN ID
13231
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Felmetatug Vedotin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

FELMETATUG VEDOTIN

Common Names & Synonyms

FELMETATUG VEDOTIN [INN]
FELMETATUG VEDOTIN [WHO-DD]
IMMUNOGLOBULIN G1, ANTI-(HUMAN/MACACA FASCICULARIS/MUS MUSCULUS B7 HOMOLOG PROTEIN B7H4) (HUMAN MONOCLONAL B7H41001 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL B7H41001 .KAPPA.-CHAIN, DIMER, REDUCED, TETRAKIS(THIOETHER) WITH N-(((4-((N-(6-(3-MERCAPTO-2,5-DIOXO-1-PYRROLIDINYL)-1-OXOHEXYL)-L-VALYL-N5-(AMINOCARBONYL)-L-ORNITHYL)AMINO)PHENYL)METHOXY)CARBONYL)-N-METHYL-L-VALYL-N-((1S,2R)-4-((2S)-2-((1R,2R)-3-(((1R,2S)-2-HYDROXY-1-METHYL-2-PHENYLETHYL)AMINO)-1-METHOXY-2-METHYL-3-OXOPROPYL)-1-PYRROLIDINYL)-2-METHOXY-1-((1S)-1-METHYLPROPYL)-4-OXOBUTYL)-N-METHYL-L-VALINAMIDE
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS VTCN1 (V-SET DOMAIN CONTAINING T CELL ACTIVATION INHIBITOR 1, B7 FAMILY MEMBER H4, B7H4, B7-H4)), HOMO SAPIENS MONOCLONAL ANTIBODY, CONJUGATED ON AN AVERAGE OF FOUR CYSTEINYL RESIDUES TO VEDOTIN, COMPRISING A CLEAVABLE LINKER AND MONOMETHYLAURISTATIN E (MMAE);

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus